NCT02489877 Comparison Between Clinical and MRI Multiple Sclerosis Activity and Expression of Human Endogenous Retrovirus Type W and Herpesvirus Status UNKNOWN Phase N/A
NCT02488343 Profile of Adherence to Therapy and Interventions to Promote Adherence in MS Status UNKNOWN Phase NA
NCT02486640 Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon Status COMPLETED Phase N/A
NCT02486562 IConquerMS™ - a Patient-Powered Research Network for Multiple Sclerosis Status RECRUITING Phase N/A
NCT02485223 Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis Status UNKNOWN Phase N/A
NCT02474134 Comparison Study of PF530 and Betaferon in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02471222 Safety and Efficacy of ADS-5102 in Patients With Multiple Sclerosis and Walking Impairment Status COMPLETED Phase PHASE2
NCT02468765 Depression and Facial Identity Recognition Abilities in Patients With Multiple Sclerosis Status COMPLETED Phase N/A
NCT02466165 Multiple Sclerosis: Associated Cardiometabolic Risks and Impact of Exercise Therapy Status COMPLETED Phase NA
NCT02466074 Augmenting Cerebral Blood Flow to Treat Established Multiple Sclerosis Status TERMINATED Phase PHASE2
NCT02463318 The Effect of Melatonin on Gene Expression and Activity of the Sirt1 and Its Target Genes Catalase and MnSOD in Multiple Sclerosis Patients and Healthy Subjects Status COMPLETED Phase NA
NCT02459821 Effects of GE-O System on Gait Impairments in Multiple Sclerosis Subjects Status UNKNOWN Phase NA
NCT02457091 Project Get Fit With MS: Guidelines for Exercise Training and Fitness Outcomes in MS Status COMPLETED Phase PHASE2
NCT02454907 The Use of Technology to Improve MS Clinical Trials and Patient Care Status COMPLETED Phase NA
NCT02454465 Evaluation of an Acceptance and Commitment Therapy Group for Adjustment Difficulties in Neurological Conditions Status COMPLETED Phase NA
NCT02446886 Adrenocorticotropic Hormone (ACTH) Effects on Myelination in Subjects With MS Status TERMINATED Phase PHASE4
NCT02442570 A Study to Evaluate Safety and Efficacy of DC-TAB in Multiple Sclerosis Status COMPLETED Phase PHASE2